Penelope Markham
Corporate Officer/Principal bij BIOVIE INC.
Vermogen: 25 308 $ op 31-03-2024
Profiel
Penelope Markham founded Influx, Inc. in 1997, where she worked as Research Director from 1997 to 2003.
Dr. Markham also currently works at BioVie, Inc., as Executive Vice President-Liver Disease Research from 2021.
Dr. Markham received her doctorate degree from Rush University, graduate degree from the University of Strathclyde, and undergraduate degree from University College Cork.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOVIE INC. CLASS A
0.08% | 16-02-2023 | 47 841 ( 0.08% ) | 25 308 $ | 31-03-2024 |
Actieve functies van Penelope Markham
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOVIE INC. | Corporate Officer/Principal | 27-04-2021 |
Eerdere bekende functies van Penelope Markham
| Bedrijven | Functie | Einde |
|---|---|---|
Influx, Inc.
 Influx, Inc. Pharmaceuticals: MajorHealth Technology Influx, Inc. discovers and develops antibiotics for difficult-to-treat infections. The company is headquartered in Chicago, IL. | Founder | 01-01-2003 |
Opleiding van Penelope Markham
| Rush University | Doctorate Degree |
| University of Strathclyde | Graduate Degree |
| University College Cork | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOVIE INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Influx, Inc.
Influx, Inc. Pharmaceuticals: MajorHealth Technology Influx, Inc. discovers and develops antibiotics for difficult-to-treat infections. The company is headquartered in Chicago, IL. | Health Technology |
